This inventor holds 1 USPTO granted patent. Top assignee: The Salk Institute. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987
Title: Janos I. Varga and GnRH Antagonist Research
Introduction
Janos I. Varga is an inventor associated with San Diego, California, and The Salk Institute. His recorded patent work concerns peptide-based gonadotropin-releasing hormone (GnRH) antagonists.
Latest Patents
Varga is listed as an inventor on 1 patent, titled “GnRH Antagonists IX.” The invention describes peptides that inhibit the pituitary gland’s secretion of gonadotropins and reduce steroid release by the gonads. The patent explains that administering an effective amount may prevent ovulation and may have potential applications in treating steroid-dependent tumors, including prostatic and mammary tumors.
The peptides are cyclic analogs of the GnRH decapeptide, with a covalent bond connecting residues at positions 4 and 10. The described bond types include disulfide, amide, dicarba, and carba linkages.
Career Highlights
Varga’s listed patent reflects research into peptide design and hormonal regulation. The described approach focuses on modifying GnRH analogs to influence reproductive hormone activity and steroid production.
Collaborations
Varga’s listed coworkers include Arnold T. Hagler and Marilyn H. Perrin. The patent record connects this work with The Salk Institute.
Conclusion
Janos I. Varga’s recorded invention explores cyclic GnRH antagonist peptides and their potential effects on ovulation and steroid-dependent conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile